These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18006768)

  • 1. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
    Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
    Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
    Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
    Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
    Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
    Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.
    Decock J; Long JR; Laxton RC; Shu XO; Hodgkinson C; Hendrickx W; Pearce EG; Gao YT; Pereira AC; Paridaens R; Zheng W; Ye S
    Cancer Res; 2007 Nov; 67(21):10214-21. PubMed ID: 17974962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
    Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
    Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
    Heist RS; Marshall AL; Liu G; Zhou W; Su L; Neuberg D; Lynch TJ; Wain J; Christiani DC
    Clin Cancer Res; 2006 Sep; 12(18):5448-53. PubMed ID: 17000679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
    Su L; Zhou W; Asomaning K; Lin X; Wain JC; Lynch TJ; Liu G; Christiani DC
    Carcinogenesis; 2006 May; 27(5):1024-9. PubMed ID: 16311244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression.
    Sun T; Gao Y; Tan W; Ma S; Zhang X; Wang Y; Zhang Q; Guo Y; Zhao D; Zeng C; Lin D
    Clin Cancer Res; 2006 Dec; 12(23):7009-17. PubMed ID: 17145822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
    Lei H; Hemminki K; Altieri A; Johansson R; Enquist K; Hallmans G; Lenner P; Försti A
    Breast Cancer Res Treat; 2007 May; 103(1):61-9. PubMed ID: 17033924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
    Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
    Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
    Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
    Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
    Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
    BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
    Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
    Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
    Su L; Zhou W; Park S; Wain JC; Lynch TJ; Liu G; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):567-70. PubMed ID: 15767330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.